AIMT - Aimmune Therapeutics Inc. (AIMT) CEO Jayson Dallas on Q1 2019 Results - Earnings Call Transcript
Aimmune Therapeutics, Inc. (AIMT)
Q1 2019 Earnings Conference Call
May 08, 2019 4:30 PM ET
Company Participants
Eric Bjerkholt - Chief Financial Officer
Jayson Dallas - President & Chief Executive Officer
Dan Adelman - Chief Medical Officer
Andrew Oxtoby - Chief Commercial Officer
Conference Call Participants
Aspen Mori - Bank of America Merrill Lynch
Charles Duncan - Cantor Fitzgerald
Chris Raymond - Piper Jaffray
John Walden - JMP Securities
Paul Choi - Goldman Sachs
Presentation
Operator
Good day, ladies and gentlemen and welcome to Aimmune Therapeutics First Quarter 2019 Earnings Conference Call. At this time,